Iqgen-X Pharma Private Limited - Company overview

Iqgen-X Pharma was incorporated on 13 October 2016 and is registered with ROC Mumbai Ii.

2016-10-13 Navi Mumbai, Maharashtra Active Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹5–10 Cr
▼ -13.6%
FY 2023
PROFIT / LOSS
Loss · ₹10–50 Lakh
▲ 86.3%
FY 2023
EBITDA
₹1–5 Cr
▲ 373.4%
FY 2023
NET WORTH
₹1–5 Cr
▲ 5.2%
FY 2023
TOTAL ASSETS
₹10–25 Cr
▼ -3.0%
FY 2023
EMPLOYEE COUNT
31–40
OPEN CHARGES
2
2.28 cr
PAID-UP CAPITAL
1.13 cr
AUTHORISED CAPITAL
2.00 cr
COMPANY AGE
10 Years 0 Months
since 2016-10-13
LAST FILING WITH ROC
2023-03-31
Last AGM: 2023-09-30
ACTIVE GST
1
Updated: 2023-02-24 15:49:52
TOTAL MONEY RAISED
₹10–25 Cr
SATISFIED CHARGES
-
-

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Iqgen-X Pharma covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Moderate
65/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (75), financial health (45), director (55) and company-foundation signals.
  • Operating for 10+ years.
Compliance Score Low risk
75/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2023 - filings look overdue.
Financial Health Score High risk
45/100
Profitability, leverage and liquidity from filed statements.
  • Loss-making in FY 2023.
  • Positive net worth.
Director Risk Score Moderate
55/100
Board strength, DIN status and churn.
  • 6 directors on the board.
  • Director PARIZAD ADIL ELCHIDANA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Iqgen-X Pharma Company identity, industry, contact, and registration details from MCA and company records.

Iqgen-X Pharma was incorporated on 13 October 2016 and is registered with ROC Mumbai Ii. It is an active private limited company, now about 10 years old. Its registered office is at A-165, Ttc Industrial Area, Khairane., Navi Mumbai, Maharashtra.

Its filings describe the main line of business as scientific research and development, which made up 100% of turnover.

It has six directors: Yatendra Kumar, Karan Jasjit Singh, Yogita Mandar Kodgule and 3 others. The longest-serving is Yatendra Kumar, on the board since 2017; the most recent to join is Parizad Adil Elchidana, appointed in September 2021. Three former directors are on record; the most recent to leave was Prabhakaran Balakrishnan Nair in September 2021. Between them, the directors also sit on the boards of 21 other companies, including Acg Ajas Components Private Limited and Acg Arts And Properties Private Limited.

Paid-up capital stands at ₹1.13 crore out of ₹2 crore authorised. The last AGM on record was on 30 September 2023, for accounts made up to 31 March 2023. Nothing newer than 2023 shows up here, so it is worth checking the MCA portal for later filings. Two charges (secured loans) are still open, with Canara Bank among the lenders.

Pharma ••••••••
  • Location A-165, Ttc Industrial Area, Khairane., Navi Mumbai, Maharashtra - 400705
  • Website iqgenx.com
LinkedIn Facebook
Legal NameIqgen-X Pharma Private Limited
CIN / LLPINU74999MH2016PTC286716
Company No.286716
ClassificationPrivate Limited Indian Non-Government Company
Incorporation Date2016-10-13
Date of AGM2023-09-30
Date of Balance Sheet2023-03-31
Listing StatusUnlisted
ROC CodeRoc Mumbai Ii
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Iqgen-X Pharma (6) Current board members from MCA filings, including designation and appointment details.

Y
Yatendra Kumar
Director | Since 2017-04-01 | DIN: 07698827
K
Karan Jasjit Singh
Additional Director | Since 2020-10-16 | DIN: 00901342
Y
Yogita Mandar Kodgule
Director | Since 2017-04-01 | DIN: 07812969
M
Mandar Madhukar Kodgule
Director | Since 2017-04-01 | DIN: 07734636
M
Madhu Hariharan
Director | Since 2017-04-01 | DIN: 06384549
P
Parizad Adil Elchidana
Additional Director | Since 2021-09-30 | DIN: 00394075

Financial Performance of Iqgen-X Pharma Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2023
Revenue ₹5–10 Cr ▼ -13.6%
P&L Loss · ₹10–50 Lakh ▲ 86.3%
EBITDA ₹1–5 Cr ▲ 373.4%
Net worth ₹1–5 Cr ▲ 5.2%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Charges of Iqgen-X Pharma Open and satisfied charges registered against the company with MCA.

Canara Bank : 2.28 cr
Open Charges: 2 Satisfied Charges: 0
Open 2.28 cr
Satisfied 0
LenderAmountStatus
Canara Bank
Creation Date: 28 Jul 2020
 28.00 Lakh Open
Canara Bank
Creation Date: 25 Sep 2017
 2.00 cr Open

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
Professional, Scientific and TechnicalScientific research and development100

Companies With Common Directors Of Iqgen-X Pharma Other companies that share directors with this entity, based on MCA and compliance network data.

Board Overlap From MCA / Compliance Filings

Acg Ajas Components Private Limited 1 Shared Director
Acg Arts And Properties Private Limited 1 Shared Director
Acg Associated Capsules Private Limited 1 Shared Director
Acg Gelatin Private Limited 1 Shared Director
Acg Inspection Systems Private Limited 1 Shared Director
Acg Metalcrafts Private Limited 1 Shared Director
Acg Pam Pharma Technologies Private Limited 1 Shared Director
Acg Pampac Machines Private Limited 1 Shared Director
Acg Pharma Technologies Private Limited 1 Shared Director
Acg Pharmagents Llp 1 Shared Director
Acg Pharmapack Private Limited 1 Shared Director
Acg Real Estate Private Limited 1 Shared Director
Acg Universal Capsules Private Limited 1 Shared Director
Acg Value Links Llp 1 Shared Director
Btf Lab Private Limited 1 Shared Director
Chemrhea Life Private Limited 1 Shared Director
Globescan Enterprises Llp 1 Shared Director
Hyphenos Software Labs Private Limited 1 Shared Director
Nutraxceed Lifesciences Private Limited 1 Shared Director
Sci-Tech Centre 1 Shared Director
Vantage Nutrition Llp 1 Shared Director

Financial Ratios of Iqgen-X Pharma Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

7 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Iqgen-X Pharma Ownership and contribution detail from filings. Full breakdown unlocks with your report.

7 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

Employees and EPFO Compliance at Iqgen-X Pharma EPFO establishments, contributions, and headcount history. Full records unlock with your report.

1 establishment linked

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

Monthly headcount PF contributions ECR filing status Establishment history

Employee and EPFO history require an active report plan.

Verified entity values are shown only after access is granted.

GST Compliance of Iqgen-X Pharma GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Iqgen-X Pharma MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Iqgen-X Pharma Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Iqgen-X Pharma Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Iqgen-X Pharma?
MCA does not publish an "owner" field. Iqgen-X Pharma is run by its directors, Yatendra Kumar, Karan Jasjit Singh, Yogita Mandar Kodgule and three others. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Iqgen-X Pharma?
Iqgen-X Pharma has six current directors: Yatendra Kumar (since April 2017), Karan Jasjit Singh (since October 2020), Yogita Mandar Kodgule (since April 2017), Mandar Madhukar Kodgule (since April 2017), Madhu Hariharan (since April 2017) and Parizad Adil Elchidana (since September 2021).
What is CIN of Iqgen-X Pharma?
The CIN of Iqgen-X Pharma is U74999MH2016PTC286716. Reading it left to right: U means it is not listed, 74999 is the industry code it registered under, MH is Maharashtra, 2016 is the year it was registered, PTC is the company type and 286716 is its registration number.
When was Iqgen-X Pharma incorporated?
Iqgen-X Pharma was incorporated on 13 October 2016 with ROC Mumbai Ii. That makes it about 10 years old.
What is the registered address of Iqgen-X Pharma?
The registered office on MCA records is A-165, Ttc Industrial Area, Khairane., Navi Mumbai, Maharashtra - 400705.
What is the current status of Iqgen-X Pharma?
MCA shows Iqgen-X Pharma as Active, and its last AGM on record was in September 2023.
What is the contact number or email for Iqgen-X Pharma?
You can post to its registered office at A-165, Ttc Industrial Area, Khairane., Navi Mumbai, Maharashtra - 400705 and use its website, https://iqgenx.com.
What industry or business activity is Iqgen-X Pharma associated with?
Its MCA filings list the main business as scientific research and development (100% of turnover).
What is paid-up capital and authorised share capital of Iqgen-X Pharma?
Paid-up capital is ₹1.13 crore and authorised capital is ₹2 crore, so about 57% of the authorised amount has been issued.
When did Iqgen-X Pharma last file accounts and hold an AGM?
The last AGM on record was on 30 September 2023, and the latest balance sheet is for the year ending 31 March 2023. Nothing newer than 2023 shows up, so check the MCA portal for later filings.
Where can I see charges and lenders for Iqgen-X Pharma?
Two charges against Iqgen-X Pharma are still open. Lenders named in the filings include Canara Bank.
Have any directors left Iqgen-X Pharma?
Yes, three former directors are on record. The most recent to leave were Prabhakaran Balakrishnan Nair (September 2021), Mousumi Satyanarayana Vemula (July 2020) and Urmila Devi Vemula (April 2017).
Which companies share directors with Iqgen-X Pharma?
21 companies share directors with Iqgen-X Pharma. Among them are Acg Ajas Components Private Limited, Acg Arts And Properties Private Limited, Acg Associated Capsules Private Limited and 18 more.
What is the turnover or revenue of Iqgen-X Pharma?
Based on filed financial statements, the revenue of Iqgen-X Pharma for FY 2023 was in the ₹5–10 Cr range. That is down 13.6% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Iqgen-X Pharma?
For FY 2023, the net worth of Iqgen-X Pharma was in the ₹1–5 Cr range.
How can I get the financial details of Iqgen-X Pharma?
The latest accounts on record are for FY 2023. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of Iqgen-X Pharma?
The website on record for Iqgen-X Pharma is https://iqgenx.com.
Which company owns iqgenx.com?
iqgenx.com is the website listed for Iqgen-X Pharma Private Limited in its company records.
Iqgen-X Pharma - is it listed or unlisted?
Iqgen-X Pharma is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Iqgen-X Pharma?
Iqgen-X Pharma is registered with ROC Mumbai Ii.
What is the company classification of Iqgen-X Pharma?
MCA classifies Iqgen-X Pharma as: Private Limited Indian Non-Government Company.
Does Iqgen-X Pharma have GST registrations on file?
Yes, one active GST registration is linked to Iqgen-X Pharma.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.